Detalhe da pesquisa
1.
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
Blood
; 121(2): 278-85, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149845
2.
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Blood
; 117(9): 2596-603, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21079154
3.
Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation.
Pediatr Blood Cancer
; 57(4): 669-73, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21495164
4.
Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.
Pediatr Blood Cancer
; 52(3): 335-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18985718
5.
Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group.
Br J Haematol
; 143(2): 261-7, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18759768
6.
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
Br J Haematol
; 141(6): 840-7, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18371107
7.
A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.
Leuk Lymphoma
; 58(10): 2370-2378, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28278717
8.
Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.
J Clin Oncol
; 20(9): 2293-301, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11981000
9.
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.
J Clin Oncol
; 30(4): 387-93, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215753
10.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Blood
; 109(7): 2773-80, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17132719
11.
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.
Blood
; 109(7): 2736-43, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17138821
12.
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality.
J Pediatr Hematol Oncol
; 28(9): 568-74, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17006262
13.
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
Br J Haematol
; 120(4): 660-70, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12588354
14.
Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience.
Am J Hematol
; 72(1): 53-63, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12508269